Squamous cell neoplasms and carcinomas of the skin

C3_SQUOMOUS_CELL_CARCINOMA_SKIN

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 C44.02, C44.12, C44.22, C44.32, C44.42, C44.52, C44.62, C44.72, C44.82, C44.92
Hospital discharge: ICD-9 173[0-9]B
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 C44.02, C44.12, C44.22, C44.32, C44.42, C44.52, C44.62, C44.72, C44.82, C44.92
Cause of death: ICD-9 173[0-9]B
Cause of death: ICD-8 $!$
Cancer registry: Topography ICD-O-3 C44
Cancer registry: Morphology ICD-O-3 807[0-7]|808[2-4]
Cancer registry: Behaviour codes [23]

18649

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

2852

diagram downward connector

Check minimum number of events None

2852

diagram downward connector

Include endpoints None

2852

diagram downward connector
C3_SQUOMOUS_CELL_CARCINOMA_SKIN

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF7

Summary Statistics

Key figures

All Female Male
Number of individuals 2852 1015 1837
Unadjusted prevalence (%) 0.80 0.51 1.17
Mean age at first event (years) 73.30 72.09 73.96

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.42 [1.82, 3.21] 1.3e-9 662
15 years 0.01 1.02 [0.80, 1.30] 8.7e-1 241
5 years 0.00 2.34 [1.90, 2.89] 1.5e-15 273
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_SQUOMOUS_CELL_CARCINOMA_SKIN – Squamous cell neoplasms and carcinomas of the skin
GWS hits:

Survival analyses between endpoints

Plot

before Squamous cell neoplasms and carcinomas of the skin
after Squamous cell neoplasms and carcinomas of the skin

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Squamous cell neoplasms and carcinomas of the skin